Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (35)

Type

TypeGuidance (4955)Indicators (319)News (351)NICE advice (498)Quality standards (257)Research recommendations (1786)

Status

StatusAwaiting development (336)Discontinued (466)In consultation (11)In development (430)Published (2572)Topic prioritisation (384)

Last updated

Last updatedLast 3 months (200)Last 6 months (374)Last year (700)Last 3 years (1436)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (392)COVID-19 rapid guidelines (27)Diagnostics guidance (89)Health technology evaluations (60)HealthTech guidance (778)Highly specialised technologies guidance (48)Interventional procedures guidance (1001)Medical technologies guidance (147)Medicines practice guidelines (5)NICE guidelines (579)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2308)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2296 to 2310 of 8910 results

Sort by

Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over [TSID12254]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lebrikizumab for treating atopic dermatitis in children [TSID12133]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Eptinezumab for preventing cluster headache attacks TSID 12087
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Linaclotide acetate for treating functional constipation in people 6 to 17 years [TSID12125]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
152
153
Current page 154
155
156
…
594
Page 154 of 594
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.